Both in Pharmaceuticals
Immix Biopharma vs Lexicon Pharmaceuticals
Over the past year IMMX returned +111.8% and LXRX returned +7.4%; their daily moves had a correlation of 0.27.
IMMX +111.8% LXRX +7.4%Growth of $1, one year, split-adjusted
| Metric | IMMX | LXRX |
|---|---|---|
| Price | $7.71 | $1.46 |
| Market cap | $639.2M | $649.6M |
| Today | +6.20% | +1.39% |
| 1 month | −23.9% | −16.1% |
| 6 months | −19.4% | −11.5% |
| Year to date | +47.4% | +27.0% |
| 1 year | +102.9% | +5.8% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.7× |
| Net cash | $232.1M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 51.9% |
| Short % of float | 22.5% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).